MAXCYTE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 290 GBX | -1.69% |
|
-7.94% | -17.73% |
| Apr. 02 | MaxCyte inks deal with Be Bio; Orcadian firms farmout | AN |
| Apr. 02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 324.00 | 420.00 | 420.00 |
| Spread/Res. | -10.49% | -30.95% | -30.95% |
| Spread/Supp. | +0.87% | +23.40% | -0.85% |
| Support | 287.50 | 235.00 | 292.50 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MXCT Stock
- Charts MaxCyte, Inc.
